Search clinical trials for: Fenoterol, ipratropium drug combination

Total 4750 results

Boehringer Ingelheim

Completed

Post-marketing Surveillance of Berodual® Metered-dose Inhaler in the Treatment of Chronic Obstructive Respiratory Tract Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Airways Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Postmarketing Surveillance Study of Berodual® Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease

Pulmonary Disease, Chronic Obstructive
Centre Hospitalier Universitaire Dinant Godinne...

Unknown

Assessment of Reactance Parameters Measured by the Forced Oscillation Technique for the Bronchodilator Response in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease
Boehringer Ingelheim

Completed

Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive | Asthma

Germany
Boehringer Ingelheim

Completed

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.

Pulmonary Disease, Chronic Obstructive | Asthma

Germany
Boehringer Ingelheim

Completed

Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition

Pulmonary Disease, Chronic Obstructive | Asthma
Boehringer Ingelheim

Completed

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Comparison to a Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma

Asthma
Boehringer Ingelheim

Completed

Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Terminated

Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients

Asthma
Boehringer Ingelheim

Completed

Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva

Pulmonary Disease, Chronic Obstructive

Netherlands
University of Sao Paulo General Hospital

Enrolling by invitation

Bronchodilators on the Exercise Capacity of Bronchiectasis Patients

Bronchiectasis Adult

Brazil
Novartis

Completed

Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction

Acute Bronchial Obstruction, Asthma

Venezuela
Hasselt University

Recruiting

Functional Strength Training and Neuromuscular Electrical Stimulation in Severe Acute Exacerbations of COPD

Acute Exacerbation of COPD | Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Belgium
Boehringer Ingelheim

Terminated

Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Neutec Ar-Ge San ve Tic A.Ş

Recruiting

Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients

COPD

Turkey
Neutec Ar-Ge San ve Tic A.Ş

Active, not recruiting

Comparison of Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination in pMDI Form in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients

COPD

Turkey
National Institute on Aging (NIA)

Completed

Initial Study of Fenoterol as a Treatment for Heart Failure

Congestive Heart Failure

United States
Fundación Pública Andaluza para la gestión de la...
Ciberned (Centro de Investigación Biomédica en Red)

Recruiting

Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease (HUNTIAM)

Huntington Disease

Spain
Assistance Publique - Hôpitaux de Paris

Withdrawn

Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension (BD-HTAP)

Pulmonary Arterial Hypertension
Boehringer Ingelheim

Completed

Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Neutec Ar-Ge San ve Tic A.Ş

Withdrawn

Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD

Chronic Obstructive Pulmonary Disease
Boehringer Ingelheim

Completed

Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment

Healthy
Boehringer Ingelheim

Terminated

Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma

Asthma
Laval University
Université de Montréal

Unknown

Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease (CODEx)

Dyspnea | Severe Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary Disease

Canada
Laval University
Pfizer; Boehringer Ingelheim

Completed

GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD) (GOLD)

Physical Activity | Respiratory Symptoms | Mild Chronic Obstructive Pulmonary Disease

Canada
US Department of Veterans Affairs

Completed

Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia

Dyspnea | Tetraplegia

United States
University Health Network, Toronto
Parkinson's Disease Foundation

Completed

Ipratropium Spray for Drooling Saliva in Parkinson's Disease

Parkinson's Disease

Canada
Kaiser Permanente

Completed

Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease

Bronchitis

United States
State University of New York at Buffalo
National Center for Advancing Translational Sciences (NCATS)

Completed

Defining and Treating Depression-related Asthma

Depression | Asthma | Childhood Asthma

United States
MetroHealth Medical Center
Sunovion

Completed

A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation

Asthma

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Single Doses of BLI-489 in Healthy Japanese Male Subjects

Healthy

Japan
Haukeland University Hospital

Completed

Atrovent in Exercise Induced Laryngeal Obstruction (EILO)

Exercise Induced Laryngeal Obstruction (EILO)

Norway
Hat Yai Medical Education Center

Recruiting

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) (PARASMA)

Asthma | Airway Obstruction | Airway Remodeling | Parasympathetic Nervous System Diseases

Thailand
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Lung Health Study (LHS) I and III

Lung Diseases | Lung Diseases, Obstructive | Chronic Obstructive Pulmonary Disease
University of California, San Francisco

Completed

Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes (STAMINA)

Bronchospasm, Exercise-Induced

United States
GlaxoSmithKline

Completed

Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive
Boehringer Ingelheim

Completed

Actuation Indicator Trial in Patients With COPD

Pulmonary Disease, Chronic Obstructive

United States
Queen's University

Completed

Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
ThromboGenics

Terminated

Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

Arterial Occlusive Diseases

Belgium
GlaxoSmithKline
University College London Hospitals

Completed

Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease

Lung Diseases, Interstitial

United Kingdom
Queen's University

Completed

Bronchodilators and Oxygen Kinetics With Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease

Canada
London Health Sciences Centre

Unknown

Ipratropium Bromide Spray as Treatment for Sialorrhea in Children

Sialorrhea
ThromboGenics
Bacchus Vascular

Terminated

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT (MAX-DVT)

Deep Vein Thrombosis

Ireland

3

Subscribe